OptiBiotix Health (OPTI) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jul 2019 07:00 AM
RNS
License agreement for LPLDL® in Japan
01 Jul 2019 07:00 AM
RNS
LPLDL® license agreement with Kappa Bioscience AS
25 Jun 2019 07:00 AM
RNS
Appointment of goetzpartners securities Limited
24 Jun 2019 07:00 AM
RNS
Manufacturing agreement with Agropur
11 Jun 2019 04:55 PM
RNS
Result of AGM
10 Jun 2019 07:00 AM
RNS
License agreement for CholBiome® in Vietnam
29 May 2019 03:17 PM
RNS
Director's Dealing
28 May 2019 07:00 AM
RNS
Appointment of CEO of ProBiotix Health
22 May 2019 07:00 AM
RNS
GoFigure® distribution agreement for Poland
20 May 2019 07:00 AM
RNS
License agreement for LPLDL®
17 May 2019 07:00 AM
RNS
Notice of AGM
14 May 2019 07:00 AM
RNS
Distribution Agreement for SlimBiome® in Thailand
07 May 2019 07:00 AM
RNS
License agreement for LPLDL®
02 May 2019 07:00 AM
RNS
Investor evening
01 May 2019 07:00 AM
RNS
SlimBiome launch to EU market at Vitafoods Europe
29 Apr 2019 07:00 AM
RNS
Final Results
24 Apr 2019 07:00 AM
RNS
SlimBiome® Medical launches in UK market
11 Apr 2019 07:00 AM
RNS
SlimBiome® receives approval from FSSAI in India
09 Apr 2019 07:00 AM
RNS
SlimBiome® Medical agreement for Bulgaria
27 Mar 2019 03:18 PM
RNS
Grant of Options
27 Mar 2019 07:43 AM
RNS
SweetBiotix®: Scientific and commercial update
27 Mar 2019 07:00 AM
RNS
SweetBiotix®: Scientific and commercial update
25 Mar 2019 11:00 AM
RNS
Price Monitoring Extension
20 Mar 2019 07:00 AM
RNS
Exclusive distribution agreement for SlimBiome®
15 Mar 2019 07:00 AM
RNS
Extension of term and territories for LPLDL®
13 Mar 2019 03:42 PM
RNS
Exercise of Warrants
21 Feb 2019 07:00 AM
RNS
LPLDL® determined GRAS by an Expert Panel in US
20 Feb 2019 07:00 AM
RNS
Presentations at ProBiota - 2019
13 Feb 2019 07:00 AM
RNS
Trading Statement
11 Feb 2019 07:00 AM
RNS
Distribution agreement for LPLDL® in Japan
07 Feb 2019 07:00 AM
RNS
Supply agreement for LPLDL® in the Baltic States
18 Jan 2019 01:56 PM
RNS
Exercise of Warrants
11 Jan 2019 07:00 AM
RNS
Director Appointment
09 Jan 2019 07:00 AM
RNS
Distribution agreement for CholBiome
07 Jan 2019 07:00 AM
RNS
Manufacturing agreement for SlimBiome®
17 Dec 2018 07:00 AM
RNS
Directorate Change
14 Dec 2018 07:00 AM
RNS
Issue of Convertible Loan Notes by ProBiotix
05 Dec 2018 02:58 PM
RNS
Holding(s) in Company
04 Dec 2018 07:00 AM
RNS
SlImBiome® Medical agreement for Greece and Cyprus
29 Nov 2018 07:00 AM
RNS
SlimBiome Medical manufacturing agreement
27 Nov 2018 07:00 AM
RNS
SlimBiome® granted medical device status & CE mark
22 Nov 2018 07:00 AM
RNS
CholBiome® agreement for Greece and Cyprus
11 Oct 2018 07:00 AM
RNS
Director's Dealing
09 Oct 2018 07:00 AM
RNS
LPLDL® US manufacturing and supply agreement
08 Oct 2018 07:00 AM
RNS
Exercise of Options & Director's Dealing
03 Oct 2018 07:00 AM
RNS
Non-exclusive distribution agreement for SlimBiome
01 Oct 2018 07:00 AM
RNS
Non-exclusive distribution agreement for SlimBiome
26 Sep 2018 07:00 AM
RNS
Distribution agreement for CholBiome®
25 Sep 2018 07:00 AM
RNS
Director/PDMR Shareholding
24 Sep 2018 07:00 AM
RNS
Formation of ProBiotix Health Limited

OptiBiotix Health Plc is a life sciences company that develops microbiome modulators to improve human health. Headquartered in York, it develops technologies to modulate the human microbiome, which is the collective genome of the microbes in the body.

OptiBiotix Health listed on the London Stock Exchange in August 2014 under the ticker OPTI.

OPTI share price launched at 2,692p.

UK 100

Latest directors dealings